As of the date of this writing, there is currently no EPA recognized test protocol to evaluate disinfection efficacy against this specific novel coronavirus virus strain, SARS-COV-2 (Severe Acute Respiratory Syndrome Coronavirus 2), which causes COVID-19 (Coronavirus Disease 2019).
As of the date of this writing, there is currently no EPA recognized test protocol to evaluate disinfection efficacy against this specific novel coronavirus virus strain, SARS-COV-2 (Severe Acute Respiratory Syndrome Coronavirus 2), which causes COVID-19 (Coronavirus Disease 2019).
This update is in response to the recent outbreak of the 2019 Novel Coronavirus or “2019-nCoV” by the U.S. Center of Disease Control (CDC), in Wuhan, China.
Metrex Research, LLC today announced a strategic partnership with the Association for Professionals in Infection Control and Epidemiology (APIC), the largest association for infection prevention and control (IPC) profess
Brea, CA (8/27/2020) — A leader in infection prevention, Metrex announces the early October 2020 launch of its new CaviWipes 2.0 surface disinfectant featuring a host of robust, in-demand features.
Excerpt: Covestro materials are used to form numerous life-saving and life-enhancing medical devices, while Metrex’s disinfectants are widely used throughout the healthcare industry.
Orange, CA – 06/04/2020 – Metrex Research, LLC has been awarded a group purchasing agreement for High Level Disinfectant and Intermediate Level Disinfectant Wipes with Premier.
ORANGE, CALIF. – April 5, 2021 – The U.S. Environmental Protection Agency (EPA) has approved all eight surface disinfectant products made by an infection prevention leader, Metrex, as effective against SARS-CoV-2, the novel coronavirus that causes COVID-19.
